CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...

Zambon Pharma has received approval from Chinese regulatory authorities and launched Fluimucil (N-acetylcysteine).

A research team was looking to make a new anti-inflammatory medication when they found some incredible side effects ...

Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...

Creatine, a naturally occurring compound, enhances athletic performance and shows potential health benefits, but caution and ...

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...